Identification and quantification of the atypical metabolite ornithine-lactam in human plasma by liquid chromatography–tandem mass spectrometry (LC–MS/MS)

In the late 1970s the atypical metabolite of ornithine, ornithine-lactam, has been observed in urine samples of patients suffering from hyperornithinemia. However, not least due to insufficient analytical methods, until now there are no data available about ornithine-lactam in human plasma. Here, we describe a new method, which is, for the first time, suitable to identify and quantify ornithine-lactam in human EDTA-plasma. The method was validated according to the requirements of the FDA guidance for bioanalytical method validation. The analytes were extracted on mixed mode cation exchange SPE columns, separated on a silica analytical HPLC column working in the HILIC mode and detected on a tandem mass spectrometer equipped with an ESI ion source. As internal standard newly synthesized stable isotope labeled D6-ornithine-lactam was used. The calibration function was linear in the range of 0.1–5 μM. Intra- and inter-day precision and accuracy was better than 14% at all concentration levels. In EDTA-plasma samples from 30 volunteers ornithine-lactam concentrations ranging from 0.136 to 0.653 μM were determined. These concentrations correlated significantly (p < 0.001, R2 = 0.784) to those of ornithine in EDTA-plasma.